Jan Roodt
- Hematology top 2%
- Immunology top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Biochemistry top 5%
- Nephrology top 5%
- Co-authors
- Seb LamprechtHans DeckmynP N BadenhorstMuriel MeiringWalter J. Janse van RensburgA. du P. HeynsStefaan RossenuSofie Priem
- Topics
- Platelet Disorders and Treatments (18 papers)Blood groups and transfusion (8 papers)Complement system in diseases (6 papers)
- Partner nations
- South AfricaBelgiumUnited States
In The Last Decade
Jan Roodt
30 papers receiving 956 citations
Peers
Comparison fields: 5 of 76
- Hematology 586
- Immunology 326
- Cardiology and Cardiovascular Medicine 169
- Biochemistry 138
- Nephrology 132
Countries citing papers authored by Jan Roodt
This map shows the geographic impact of Jan Roodt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Roodt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Roodt more than expected).
Fields of papers citing papers by Jan Roodt
This network shows the impact of papers produced by Jan Roodt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Roodt. The network helps show where Jan Roodt may publish in the future.
Co-authorship network of co-authors of Jan Roodt
This figure shows the co-authorship network connecting the top 25 collaborators of Jan Roodt. A scholar is included among the top collaborators of Jan Roodt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Roodt. Jan Roodt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 47 | |
| 3 | 4 | |
| 4 | 27 | |
| 5 | 106 | |
| 6 | 4 | |
| 7 | 17 | |
| 8 | 54 | |
| 9 | 13 | |
| 10 | 106 | |
| 11 | Rational humanization of the powerful antithrombotic anti-GPIbalpha antibody: 6B4. | 27 |
| 12 | 23 | |
| 13 | 1 | |
| 14 | 11 | |
| 15 | 13 | |
| 16 | 29 | |
| 17 | 31 | |
| 18 | 51 | |
| 19 | Comparison of oxine and tropolone methods for labeling human platelets with indium-111. | 24 |
| 20 | In-111-labeled platelet kinetic studies identify those patients with chronic ITP who will respond to intravenous gammaglobulin. | 1 |
About Jan Roodt
Jan Roodt is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine, having authored 30 papers that have together received 980 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (18 papers), Blood groups and transfusion (8 papers) and Complement system in diseases (6 papers). The work is most often cited by research in Hematology (586 citations), Internal Medicine (107 citations) and Biochemistry (138 citations). Jan Roodt has collaborated with scholars based in South Africa, Belgium and United States. Frequent co-authors include Seb Lamprecht, Hans Deckmyn, P N Badenhorst, Muriel Meiring, Walter J. Janse van Rensburg, A. du P. Heyns, Stefaan Rossenu, Sofie Priem, Hans Ulrichts and Josefin-Beate Holz. Their work appears in journals such as Blood, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.